Academic Journal
Q1European Journal of Human Genetics
About European Journal of Human Genetics
About European Journal of Human Genetics
European Journal of Human Genetics is a peer-reviewed scholarly journal published by Springer Nature (Switzerland). It focuses on Q1. Publication coverage spans 1993-2026.
Key indicators: ISSN 1018-4813, 1476-5438; H-index 153.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (153): Exceptionally high — 153 articles have each been cited at least 153 times. This indicates deep, sustained influence in the field.
Publishing in European Journal of Human Genetics
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of European Journal of Human Genetics?
1018-4813, 1476-5438.
Who publishes European Journal of Human Genetics?
Springer Nature.
What are European Journal of Human Genetics's metrics?
H-index 153.
Is European Journal of Human Genetics peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Genomics and Rare Diseases; Genomic variations and chromosomal abnormalities; BRCA gene mutations in cancer; Genetic Associations and Epidemiology; Genetics and Neurodevelopmental Disorders; Prenatal Screening and Diagnostics.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
2,790.00 USD; 4,090.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Optimized RNA-seq workflow for routine diagnosis of mitochondrial diseases using aberrant expression analysis and phenotype-driven prioritization
Lucile Riera-Navarro, Eléonore Birgy, Samira Ait-El-Mkadem Saadi, Alexandre Janin et al.
2026-10-12 · DOI: 10.1038/s41431-026-02256-xCharacterisation of a Portuguese origin founder missense variant in MSH6
Kenzie Melvill, Leora Witkowski, Céline Domecq, Nancy Hamel et al.
2026-10-09 · DOI: 10.1038/s41431-026-02248-xGenetic testing and counselling of patients with monogenic amyotrophic lateral sclerosis in Northern Finland: a retrospective, single-centre study
Maari Kytöharju, Jukka S. Moilanen, Mika H. Martikainen
2026-10-08 · DOI: 10.1038/s41431-026-02246-zParental reactions to and preferences for genomic newborn screening in Germany: findings from a scenario-based survey experiment
Elena Sophia Doll, Julia Mahal, Karla Alex, Carlotta Julia Mayer et al.
2026-10-08 · DOI: 10.1038/s41431-026-02253-0Healthcare professionals’ views on expanding newborn screening with or without genomics in France: Results of the SeDeN-p2 study
Camille Level, Frédéric Huet, Dominique Salvi, Christel Thauvin Robinet et al.
2026-10-06 · DOI: 10.1038/s41431-026-02250-3Health inequalities in precision medicine: A systematic review
Zeinab M. Hassanein, Manpreet Bains, Rupinder Kaur Bajwa, Jo Leonardi-Bee et al.
2026-10-06 · DOI: 10.1038/s41431-026-02225-4Gene-specific reclassification patterns of variants in hypertrophic cardiomyopathy
Athanasios Bakalakos, Rebeca Lorca, Alexandros Protonotarios, Douglas Ewan Cannie et al.
2026-10-06 · DOI: 10.1038/s41431-026-02227-2Diagnostic pathways in developmental disorders: a decade-apart comparison of two multicenter cohorts (2012–2022)
Julien Maraval, Céline Dampfhoffer, Antoine Journé, Céline Poitevin et al.
2026-10-06 · DOI: 10.1038/s41431-026-02242-3Patient harms during delayed access to clinical genetics services. A systematic literature review and synthesis without meta-analysis (SWiM)
Michaela Cormack, Janet Long, Alan Ma, Nabila Binte Haque et al.
2026-10-05 · DOI: 10.1038/s41431-026-02247-yCharacterising the ‘Genomics Friend’: Experiences of learning genomics in the workplace to inform implementation efforts
Alice Kim, Jennifer Weller-Newton, Louise Keogh, Amy Nisselle et al.
2026-10-03 · DOI: 10.1038/s41431-026-02245-0Genomics cycle: discover, diagnose, interpret, act
Seda S. Zonuzi
2026-10 · DOI: 10.1038/s41431-026-02251-2Insertion or deletion variants in TAF15 exon 15 are genetic factors impacting the prognosis of amyotrophic lateral sclerosis in a Japanese cohort
Yuya Hatano, Tomohiko Ishihara, Mari Tada, Yutong Li et al.
2026-10-01 · DOI: 10.1038/s41431-026-02249-wExpanded carrier screening in China: a focused narrative review and conceptual implementation framework
Liling Liu, Honglian Wu, Ming Zhang, Yinghui Ye et al.
2026-09-30 · DOI: 10.1038/s41431-026-02252-1Manufactured gametes and the principle of genetic caution
Joona Räsänen, Adrian Villalba, Julian Savulescu
2026-09-30 · DOI: 10.1038/s41431-026-02254-zReanalysis of genomic data doubles the diagnostic yield for Welsh patients recruited to the UK 100,000 Genomes Project
Jana Jezkova, Martin A. McClatchey, Sophie Shaw, Rhys Vaughan et al.
2026-09-28 · DOI: 10.1038/s41431-026-02234-3Interdisciplinary management and genetic evaluation of pediatric cancer predisposition syndromes: a retrospective cohort study
Nicola Dikow, Anna Lisa Nitschke, Steffen Hirsch, Eva Roth et al.
2026-09-25 · DOI: 10.1038/s41431-026-02244-15q31 duplications encompassing PURA are associated with a neurodevelopmental disorder
Laurine Challeat, Solène Remize, Tarek Alouane, David Laurenceau et al.
2026-09-22 · DOI: 10.1038/s41431-026-02230-7digitalMLPA EZtec-MS: A new highly multiplexed DNA probe-based technique for neonatal screening
Terence Diane Fabella, Joery den Hoed, Eva Maria Cutiongco-de la Paz, Carmencita Padilla et al.
2026-09-22 · DOI: 10.1038/s41431-026-02235-2Biallelic DAW1 variants reveal a tissue-specific role in heterotaxy without primary ciliary dyskinesia
Dana Urbatsch, Anburaj Jeyaraj, Shruti Bedekar, Venkatramanan Rao et al.
2026-09-22 · DOI: 10.1038/s41431-026-02228-1The difficulties of developing guidelines for rare disease: where consensus, evidence-based medicine and screening principles conflict
Andrew Latchford, Terri McVeigh
2026-09-21 · DOI: 10.1038/s41431-026-02241-4Reviews
Community Reviews
Version History
October 9, 2026 at 7:12 pm
September 25, 2026